CRIS Current Research Information System

MACCHINI, MARINA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.967
EU - Europa 1.801
AS - Asia 718
AF - Africa 138
SA - Sud America 6
OC - Oceania 2
Totale 4.632
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.964
GB - Regno Unito 475
VN - Vietnam 323
IT - Italia 294
SE - Svezia 285
CN - Cina 265
DE - Germania 200
CH - Svizzera 108
IN - India 95
IE - Irlanda 90
UA - Ucraina 87
RU - Federazione Russa 72
FR - Francia 71
ZA - Sudafrica 45
TG - Togo 41
EE - Estonia 35
NG - Nigeria 32
BG - Bulgaria 20
BE - Belgio 16
JO - Giordania 15
FI - Finlandia 14
CI - Costa d'Avorio 10
AT - Austria 8
IR - Iran 7
SC - Seychelles 6
HR - Croazia 5
NL - Olanda 5
SG - Singapore 4
CA - Canada 3
ES - Italia 3
GR - Grecia 3
PL - Polonia 3
PT - Portogallo 3
AU - Australia 2
BR - Brasile 2
CL - Cile 2
CM - Camerun 2
LB - Libano 2
SK - Slovacchia (Repubblica Slovacca) 2
TR - Turchia 2
CZ - Repubblica Ceca 1
DZ - Algeria 1
EC - Ecuador 1
IL - Israele 1
JP - Giappone 1
MU - Mauritius 1
PE - Perù 1
RO - Romania 1
SA - Arabia Saudita 1
TW - Taiwan 1
UZ - Uzbekistan 1
Totale 4.632
Salva come PNG Salva come JPEG
Città #
Southend 437
Chandler 237
Fairfield 208
Dong Ket 204
Ashburn 156
Princeton 118
Houston 106
Bern 105
Wilmington 101
Ann Arbor 91
Dublin 90
New York 86
Woodbridge 80
Seattle 69
Cambridge 57
Jacksonville 56
Westminster 47
Nanjing 46
Padova 45
Lomé 41
Bologna 36
Medford 35
Abeokuta 32
Turin 31
Berlin 30
Shenyang 29
Saint Petersburg 24
Florence 22
Jinan 21
Mülheim 20
Sofia 20
Dearborn 19
Hebei 19
Beijing 17
Changsha 16
Amman 15
Helsinki 14
Los Angeles 14
Nanchang 14
Fremont 13
Redwood City 13
Brussels 12
San Diego 12
Falls Church 11
Jiaxing 11
Tianjin 11
Abidjan 10
Des Moines 10
Milan 10
Ravenna 10
Taiyuan 10
Boardman 9
San Venanzo 9
Rome 8
Haikou 7
Hangzhou 7
Olalla 7
Kunming 6
Mahé 6
Norwalk 6
Torino 6
Vienna 6
Guangzhou 5
Monmouth Junction 5
Taizhou 5
Ardabil 4
Bremen 4
Bühl 4
Groningen 4
Hefei 4
Kiev 4
Lanzhou 4
Leawood 4
Mumbai 4
Phoenix 4
Zhengzhou 4
Cesena 3
Kuban 3
Mountain View 3
Ningbo 3
Bastiglia 2
Buffalo 2
Casalecchio Di Reno 2
Chicago 2
Costa Mesa 2
Frankfurt am Main 2
Grafing 2
Istanbul 2
Luzzara 2
Madrid 2
Parma 2
Piacenza 2
Plauen 2
Provo 2
Romainville 2
Ružomberok 2
San Francisco 2
Toronto 2
Verona 2
Warsaw 2
Totale 3.129
Salva come PNG Salva come JPEG
Nome #
Follow-up del cancro del pancreas esocrino 191
Characterization of pancreatic ductal adenocarcinoma patients using whole-transcriptome sequencing and copy number analysis by SNPs array techniques. 179
Characterization of pancreatic ductal adenocarcinoma using whole transcriptome sequencing and copy number analysis by single-nucleotide polymorphism array 179
Antiprotease strategy in combination with gemcitabine as a putative novel therapeutic approach for pancreatic cancer treatment 169
Chemotherapy followed by chemoradiotherapy in locally advanced pancreatic cancer:A literature review and report of two cases 161
Antiprotease strategy in pancreatic cancer treatment: emergence from a preclinical study. 159
Comparing recist and Choi’s criteria to evaluate radiological response to chemotherapy in patients with advanced pancreatic cancer 148
Clinical impact of nonselective beta-blockers on survival in patients with pancreatic cancer- revival of well known drugs? 128
Venous thromboembolism and port-related thrombosis in metastatic colorectal cancer patients: a monocenter experience. 120
Neoadjuvant therapy for resectable pancreatic adenocarcinoma: An interim report of a prospective randomized study 119
Comparing RECIST and Choi's Criteria After Neoadjuvant Chemoradiotherapy in Patients with Resectable Pancreatic Cancer 119
GemOx and Ovarian Pancreatic Cancer Metastasis (PC) 114
Advanced pancreatic cancer (APC) A monocenter experience in 53 patients: is it possible a second line treatment? 111
State of the art biological therapies in pancreatic cancer 109
CIRCULATING METALLOPROTEINASE-3 AND TISSUE INHIBITOR OF METALLOPROTEINASE-2 IN PATIENTS WITH DUCTAL PANCREATIC NEOPLASMS 107
Hedgehog Signaling: from the Cuirass to the Heart of Pancreatic Cancer 104
β2 Adrenergic-Neurotrophin Feedforward Loop Promotes Pancreatic Cancer 103
Comparing RECIST and Choi’s Criteria to Evaluate Radiological Response to Chemotherapy in Patients with Advanced Pancreatic Cancer 98
Retroperitoneal lymphangioma: A report of 2 cases and a review of the literature regarding the differential diagnoses of retroperitoneal cystic masses 96
Metastatic pancreatic cancer: is gemcitabine still the best standard treatment? 95
Preoperatory Gemcitabine and Oxaliplatin in a patient with ovarian metastasis from pancreatic cystadenocarcinoma 92
Gemox in combination witherlotinib (E) in pancreatic cancer (PC). 90
Prognostic factors for recurrence in resected pancreatic adenocarcinoma: a single center experience 90
Role of adjuvant chemoradiotherapy (CRT) and chemotherapy alone in pancreatic cancer: experience in 25 patients. 88
Useful of Choi’s criteria after neoadjuvant chemoradiotherapy in patients with resectable pancreatic cancer. 88
Advanced pancreatic cancer (apc); a Monocenter experience in 53 patients. It is possible a second line treatment? 87
Long-Term Survival After Pancreaticoduodenectomy for Pancreatic Ductal Adenocarcinoma. Case Report 85
Comparing RECIST and Choi’s Criteria to Evaluate Radiological Response to Chemotherapy in Patients with Resectable and Advanced Pancreatic Cancer. 83
Prognostic factors in resected pancreatic cancer:a single centre experience 82
The Protease Inhibitor Gabexate Mesylate Reduces Invasiveness and Angiogenesis in Pancreatic Cancer Cell Lines, Enhancing Gemcitabine Action 82
GEMOX AS FIRST-LINE CHEMOTHERAPY IN ADVANCED PANCREATIC CANCER (APC): A MONOINSTITUTIONAL EXPERIENCE 81
Erratum: β2 Adrenergic-Neurotrophin Feedforward Loop Promotes Pancreatic Cancer (Cancer Cell (2018) 33(1) (75–90.e7), (S153561081730510X) (10.1016/j.ccell.2017.11.007)) 79
Neoadjuvant therapy for resectable pancreatic adenocarcinoma: an interim report of a prospective controlled randomized study. 76
Germinal BRCA1-2 pathogenic variants (gBRCA1-2pv) and pancreatic cancer: epidemiology of an Italian patient cohort 76
The follow-up issues: from the necessity to the opportunity 75
Locally Advanced Pancreatic Cancer: Is It Possible Pancreatic Resection? A Case Report 74
Whole Transcriptome Sequencing Reveals Molecular Prognostic Markers in Pancreatic Adenocarcinoma 72
Neoadjuvant Therapy for Resectable Pancreatic Adenocarcinoma: An Interim Report of a Prospective Controlled Randomized Study 72
Massively Parallel Sequencing Analysis of Genetic Alterations Carried by Pancreatic Adenocarcinoma 69
Whole-transcriptome paired-end sequencing and the pancreatic cancer genetic landscape 69
New WHO classification for pancreatic endocrine tumours: is time to leave the previous one 61
Role of CA 19-9 Concentration as an Independent Prognostic Factor in Unresectable Pancreatic Ductal Adenocarcinoma (PDCA) Treated with GemOx 60
Resection Margin Involvement in Pancreaticoduodenectomy. A Single Centre Experience 60
Whole Transcriptome Sequencing Reveals Somatic HMGCR Mutation in a Case of Pancreatic Adenocarcinoma with Long-Term Therapy Response 60
SNP-Array High Resolution Cytogenetic Analysis of Resectable and Advanced Pancreatic Cancer 58
Whole genome discovery of genetic alterations carried by pancreatic adenocarcinoma 53
Massively Parallel Sequencing Analysis of Genetic Alterations Carried by Pancreatic Adenocarcinoma 52
Whole genome discovery of genetic alterations in resectable and advanced pancreatic cancer. 50
Chemotherapy toxicity and activity in patients with pancreatic ductal adenocarcinoma and germline BRCA1-2 pathogenic variants (gBRCA1-2pv): a multicenter survey 49
Germinal BRCA1-2 pathogenic variants (gBRCA1-2pv) and pancreatic cancer: epidemiology of an Italian patient cohort 27
Second-line therapy in pancreatic ductal adenocarcinoma (PDAC) patients with germline BRCA1-2 pathogenic variants (gBRCA1-2pv) 25
Guideline Application in Real world: multi-Institutional Based survey of Adjuvant and first-Line pancreatic Ductal adenocarcinoma treatment in Italy. Primary analysis of the GARIBALDI survey 10
Totale 4.784
Salva come PNG Salva come JPEG
Categoria #
all - tutte 10.527
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 10.527
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201981 0 0 0 0 0 0 0 0 0 0 8 73
2019/2020958 213 46 13 58 62 82 90 99 120 64 50 61
2020/2021775 126 19 14 18 11 35 15 44 69 30 32 362
2021/2022994 80 44 30 70 89 51 13 57 38 107 240 175
2022/20231.238 105 173 69 133 80 102 13 84 169 51 135 124
2023/2024364 26 44 10 37 34 135 17 31 9 21 0 0
Totale 4.784